{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:53:51Z","timestamp":1775210031606,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1985,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/ki.2010.84","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T15:47:08Z","timestamp":1270655228000},"page":"79-88","source":"Crossref","is-referenced-by-count":32,"title":["Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production"],"prefix":"10.1016","volume":"78","author":[{"given":"Sibylle","family":"von Vietinghoff","sequence":"first","affiliation":[]},{"given":"Hui","family":"Ouyang","sequence":"additional","affiliation":[]},{"given":"Klaus","family":"Ley","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.84_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andres","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/ki.2010.84_bb0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","author":"Group","year":"1996","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.84_bb0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/01.TP.0000071522.74885.48","article-title":"Mycophenolatemofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients","volume":"76","author":"Pfitzmann","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.84_bb0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1399-0012.2008.00820.x","article-title":"Adverse drug reaction driven immunosuppressive drug manipulations: a single-center comparison of enteric-coated mycophenolate sodium vs mycophenolate mofetil","volume":"22","author":"Hardinger","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1038\/ki.2010.84_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transproceed.2006.10.216","article-title":"Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients: pooled results from three international, multicenter studies","volume":"39","author":"Pietruck","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.84_bb0035","first-page":"43","article-title":"Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial","volume":"5","author":"Sterneck","year":"2000","journal-title":"Ann Transplant"},{"key":"10.1038\/ki.2010.84_bb0040","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1600-6143.2009.02699.x","article-title":"Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study","volume":"8","author":"Zafrani","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.84_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1038\/ki.2010.84_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-200002000-00004","article-title":"Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients","volume":"22","author":"Oellerich","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1038\/ki.2010.84_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00007691-200002000-00005","article-title":"Pharmacokinetics of mycophenolic acid in renal insufficiency","volume":"22","author":"Meier-Kriesche","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1038\/ki.2010.84_bb0060","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1185\/030079906X148481","article-title":"Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome","volume":"22","author":"Kaplan","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1038\/ki.2010.84_bb0065","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1600-6143.2009.02678.x","article-title":"Mycophenolate blood level monitoring: recent progress","volume":"9","author":"van Gelder","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2010.84_bb0070","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.84_bb0075","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.84_bb0080","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2010.84_bb0085","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2215\/CJN.01200307","article-title":"Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis","volume":"2","author":"Walsh","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0090","doi-asserted-by":"crossref","first-page":"c100","DOI":"10.1159\/000089667","article-title":"Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis","volume":"102","author":"Koukoulaki","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2010.84_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2010.84_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cbpa.2006.08.005","article-title":"IMP dehydrogenase: structural schizophrenia and an unusual base","volume":"10","author":"Hedstrom","year":"2006","journal-title":"Curr Opin Chem Biol"},{"key":"10.1038\/ki.2010.84_bb0105","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2010.84_bb0110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4049\/jimmunol.152.3.984","article-title":"Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression","volume":"152","author":"Dayton","year":"1994","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1038\/ki.2010.84_bb0120","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.170.10.4986","article-title":"Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides","volume":"170","author":"Quemeneur","year":"2003","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0125","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1128\/MCB.23.18.6702-6712.2003","article-title":"Targeted disruption of the inosine 5\u2032-monophosphate dehydrogenase type I gene in mice","volume":"23","author":"Gu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2010.84_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-3274(98)80031-2","article-title":"Mycophenolate mofetil reduces production of interferon-dependent major histocompatibility complex induction during allograft rejection, probably by limiting clonal expansion","volume":"6","author":"Lui","year":"1998","journal-title":"Transplant Immunol"},{"key":"10.1038\/ki.2010.84_bb0135","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.4049\/jimmunol.173.8.4945","article-title":"Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells","volume":"173","author":"Quemeneur","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0140","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.V981407","article-title":"Attenuation of murine lupus nephritis by mycophenolate mofetil","volume":"9","author":"Van Bruggen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1681\/ASN.V134937","article-title":"Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis","volume":"13","author":"Nieto","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0150","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","article-title":"Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition","volume":"9","author":"Penny","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-03-079681","article-title":"Hematopoietic cytokines","volume":"111","author":"Metcalf","year":"2008","journal-title":"Blood"},{"key":"10.1038\/ki.2010.84_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2008.03.002","article-title":"Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and \u2018emergency\u2019 hematopoiesis","volume":"42","author":"Panopoulos","year":"2008","journal-title":"Cytokine"},{"key":"10.1038\/ki.2010.84_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00062752-200701000-00003","article-title":"Regulation of neutrophil homeostasis","volume":"14","author":"Christopher","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/ki.2010.84_bb0170","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.181.8.5183","article-title":"Homeostatic regulation of blood neutrophil counts","volume":"181","author":"von Vietinghoff","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0175","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2004-07-2856","article-title":"Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells","volume":"105","author":"Monteiro","year":"2005","journal-title":"Blood"},{"key":"10.1038\/ki.2010.84_bb0180","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.161.11.6383","article-title":"IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines","volume":"161","author":"Schwarzenberger","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0185","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/blood.V98.12.3309","article-title":"Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice","volume":"98","author":"Forlow","year":"2001","journal-title":"Blood"},{"key":"10.1038\/ki.2010.84_bb0190","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/IAI.73.1.617-621.2005","article-title":"Interleukin-17\/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection","volume":"73","author":"Kelly","year":"2005","journal-title":"Infect Immun"},{"key":"10.1038\/ki.2010.84_bb0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4049\/jimmunol.181.2.1357","article-title":"IL-17A inhibits the expansion of IL-17A-producing T cells in mice through \u2018short-loop\u2019 inhibition via IL-17 receptor","volume":"181","author":"Smith","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0200","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.176.10.6186","article-title":"IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation","volume":"176","author":"Tan","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2010.84_bb0210","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.exphem.2008.06.003","article-title":"IL-17F\/IL-17R interaction stimulates granulopoiesis in mice","volume":"36","author":"Tan","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1038\/ki.2010.84_bb0215","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.4049\/jimmunol.179.8.5462","article-title":"Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F","volume":"179","author":"Kuestner","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.175.1.404","article-title":"Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis","volume":"175","author":"McAllister","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","article-title":"Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17","volume":"22","author":"Stark","year":"2005","journal-title":"Immunity"},{"key":"10.1038\/ki.2010.84_bb0235","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2010.84_bb0240","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1038\/ki.2010.84_bb0245","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0250","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0255","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/BOR.0b013e328304b6b5","article-title":"IL-17 and the Th17 lineage in systemic lupus erythematosus","volume":"20","author":"Garrett-Sinha","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/ki.2010.84_bb0260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2010.84_bb0265","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.4049\/jimmunol.181.5.3456","article-title":"IL-17A produced by gammadelta T cells plays a critical role in innate immunity against Listeria monocytogenes infection in the liver","volume":"181","author":"Hamada","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0270","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0275","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette\u2013Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/TP.0b013e3181664e54","article-title":"Effect of the antioxidant idebenone on adverse events under mycophenolate mofetil therapy in a rat model","volume":"85","author":"Heller","year":"2008","journal-title":"Transplantation"},{"key":"10.1038\/ki.2010.84_bb0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0290","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","author":"European Mycophenolate Mofetil Cooperative Study Group","year":"1995","journal-title":"Lancet"},{"key":"10.1038\/ki.2010.84_bb0295","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/ki.2010.84_bb0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.immuni.2008.04.022","article-title":"Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma","volume":"29","author":"Jensen","year":"2008","journal-title":"Immunity"},{"key":"10.1038\/ki.2010.84_bb0305","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2006-04-015016","article-title":"T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype","volume":"108","author":"Mathur","year":"2006","journal-title":"Blood"},{"key":"10.1038\/ki.2010.84_bb0310","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0315","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1074-7613(02)00319-9","article-title":"Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M","volume":"16","author":"Broxmeyer","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/ki.2010.84_bb0320","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.transproceed.2009.08.031","article-title":"Differential effect of cyclosporine and mycophenolic acid on the human regulatory T cells and TH-17 cells balance","volume":"41","author":"Abadja","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.84_bb0325","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/ard.2008.096743","article-title":"Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK\/STAT pathway","volume":"68","author":"Gonzalez-Alvaro","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/ki.2010.84_bb0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2008.12.003","article-title":"Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood","volume":"45","author":"Liu","year":"2009","journal-title":"Cytokine"},{"key":"10.1038\/ki.2010.84_bb0335","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI8669","article-title":"Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene","volume":"106","author":"Gu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2010.84_bb0340","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.4049\/jimmunol.169.5.2747","article-title":"Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis","volume":"169","author":"Quemeneur","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0345","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/path.1117","article-title":"Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection","volume":"197","author":"Loong","year":"2002","journal-title":"J Pathol"},{"key":"10.1038\/ki.2010.84_bb0350","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1681\/ASN.V981526","article-title":"Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection","volume":"9","author":"Van Kooten","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0355","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.transproceed.2008.09.043","article-title":"T(H)17 versus treg cells in renal transplant candidates: effect of a previous transplant","volume":"40","author":"San Segundo","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.84_bb0360","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.4049\/jimmunol.181.6.3906","article-title":"CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice","volume":"181","author":"Burrell","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2010.84_bb0365","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.2009030337","article-title":"Th1 and Th17 cells induce proliferative glomerulonephritis","volume":"20","author":"Summers","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0370","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1681\/ASN.2008050556","article-title":"The IL-23\/Th17 axis contributes to renal injury in experimental glomerulonephritis","volume":"20","author":"Paust","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0375","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.2008080891","article-title":"IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen","volume":"20","author":"Ooi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2010.84_bb0380","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1038\/ki.2010.84_bb0385","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.transproceed.2005.02.038","article-title":"Mycophenolate mofetil-induced neutropenia in liver transplantation","volume":"37","author":"Nogueras","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2010.84_bb0390","article-title":"Colony stimulating factors for chemotherapy induced febrile neutropenia","volume":"CD003039","author":"Clark","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1038\/ki.2010.84_bb0395","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","article-title":"Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial","volume":"29","author":"Caproni","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1038\/ki.2010.84_bb0400","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"10.1038\/ki.2010.84_bb0405","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1093\/nar\/gng154","article-title":"A PCR primer bank for quantitative gene expression analysis","volume":"31","author":"Wang","year":"2003","journal-title":"Nucleic Acids Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:53:35Z","timestamp":1685559215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815544001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0085253815544001"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.84","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}